Nichols Asset Management’s Abiomed Inc ABMD Stock Holding History

Nichols Asset Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-139,854	Closed	-$13.3M	–	103
2016 Q1	$13.3M	Sell	139,854 -1,151	-0.8%	-$97.2K	2.92%	1
2015 Q4	$12.7M	Sell	141,005 -371	-0.3%	-$31.5K	2.77%	1
2015 Q3	$13.1M	Sell	141,376 -12,638	-8%	-$1.11M	2.93%	1
2015 Q2	$10.1M	Sell	154,014 -95,660	-38%	-$6.36M	1.81%	18
2015 Q1	$17.9M	Sell	249,674 -22,299	-8%	-$1.21M	3.13%	1
2014 Q4	$10.4M	Sell	271,973 -6,803	-2%	-$215K	2.03%	4
2014 Q3	$6.92M	Buy	+278,776	New	+$7.06M	1.43%	45

Other funds holding ABMD

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nichols Asset Management's ABMD Position: Q2 2016 in Review

Nichols Asset Management sold out of Abiomed Inc (ABMD) in Q2 2016, closing a stake of 139,854 shares — an estimated $13.3M sold.

Nichols Asset Management first reported a position in ABMD in Q3 2014 and held it in 7 quarters. The position peaked at $17.9M in Q1 2015. 297 funds tracked by Wall St. Rank hold ABMD as of Q2 2016.

Nichols Asset Management reported no remaining Abiomed Inc position as of Q2 2016 after selling out during the quarter.
Nichols Asset Management sold 139,854 Abiomed Inc shares in Q2 2016, an estimated $13.3M.
Nichols Asset Management first reported a position in Abiomed Inc in Q3 2014 and held it in 7 quarters.
Nichols Asset Management's Abiomed Inc position peaked at $17.9M in Q1 2015.
297 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2016.

Based on Nichols Asset Management's 13F filing for Q2 2016, filed 5 Aug 2016.